国家肺癌筛查试验中以部分实性结节为表现的肺癌
研究分析国家肺癌筛查试验(NLST)中以部分实性结节为表现的肺癌,88例筛查诊断的混合结节经复核确认19例为部分实性结节,均见于基线,无淋巴结增大或转移,18例手术患者无肺癌死亡,整个结节中位体积倍增时间476天,实性成分240天。
要点
- NLST中部分实性结节肺癌均见于基线筛查,诊断前CT无淋巴结增大,切除时无转移。
- 实性成分平均9.2 mm,5例大于10 mm;整个结节中位体积倍增时间476天,实性成分240天。
- 18例单发或主导部分实性结节患者均手术,随访期间无肺癌死亡。
核心结论
- 以单发或主导部分实性结节为表现的肺癌患者均无淋巴结增大或病理转移,在NLST随访时间内无肺癌死亡。
研究设计与样本
- 基于国家肺癌筛查试验(NLST)的影像分析,88例经NLST放射科医生分类为混合结节的筛查诊断肺癌由4名经验丰富放射科医生复核再分类。
关键影像表现/征象
- 部分实性结节均见于基线(时间0),诊断前CT无淋巴结增大,切除时无转移。
- 诊断前末次CT上部分实性结节实性成分平均大小9.2 mm(SD 4.9),5例实性成分大于10 mm。
- 整个结节中位体积倍增时间476天,实性成分中位体积倍增时间240天。
诊断标准与关键数值
- 88例NLST放射科医生分类为混合结节的筛查诊断肺癌中,研究放射科医生确认19例为部分实性结节。
- 部分实性结节中实性成分大于10 mm者5例。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The objective of our study was to determine how often death occurred from lung cancers that manifested as part-solid nodules in the National Lung Screening Trial (NLST).
MATERIALS AND METHODS: NLST radiologists classified nodules as solid, ground-glass, or mixed. All lung cancers classified as mixed nodules by NLST radiologists were reviewed by four experienced radiologists and reclassified as solid, nonsolid, or part-solid nodules. When possible, volume doubling times (VDTs) were calculated separately for the entire nodule and for the solid component of the nodule.
RESULTS: Of 88 screening-diagnosed lung cancer cases identified by the NLST radiologists as mixed nodules, study radiologists confirmed that 19 were part-solid nodules. All the part-solid nodules were present at baseline (time 0), and none of the patients with a part-solid nodule had lymph node enlargement at CT before diagnosis or metastases at resection. Multilobar stage IV (T4N0M1) bronchioloalveolar carcinoma was diagnosed in one patient 25.0 months after study randomization, and the patient died 67.9 months after randomization. All 18 patients with a solitary or dominant part-solid nodule underwent surgery, and none died of lung cancer. From randomization, the average time to diagnosis was 18.6 months and the average time of follow-up was 79.2 months. On the last CT examination performed before diagnosis, the average size of the solid component of the part-solid nodules was 9.2 mm (SD, 4.9); the solid component was larger than 10 mm in five patients. The median VDT based on the entire nodule was 476 days, and the median VDT based on the solid component alone was 240 days.
CONCLUSION: None of the patients with lung cancer manifesting as a solitary or dominant part-solid nodule had lymph node enlargement or metastases at pathology, and none died of lung cancer within the follow-up time of the NLST.
引用
- Yip R, Henschke CI, Xu DM, et al. Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial. AJR Am J Roentgenol. 2017. PMID: 28245151. doi:10.2214/AJR.16.16930
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。